Hydroxyethylstarch as a replacement fluid in therapeutic plasma exchange for lupus nephritis in a Jehovah's Witness. (يفتح نافذة جديدة)

Cid J, Ortín X, Elies E, Díaz E.

Source‎: Transfus Apher Sci 2003;28(1):101-2.

مفهرسة‎: PubMed 12620275

DOI‎: 10.1016/S1473-0502(02)00105-2

https://www.ncbi.nlm.nih.gov/pubmed/12620275 (يفتح نافذة جديدة)

Successful management of a Jehovah's Witness with thrombotic thrombocytopenic purpura unwilling to be treated with therapeutic plasma exchange. (يفتح نافذة جديدة)

Dabak V, Kuriakose P, Raman S.

Source‎: J Clin Apher 2007;22(6):330-2.

مفهرسة‎: PubMed 18080270

DOI‎: 10.1002/jca.20150

https://www.ncbi.nlm.nih.gov/pubmed/18080270 (يفتح نافذة جديدة)

Bovine hemoglobin: a nontraditional approach to the management of acute anemia in a Jehovah's Witness patient with autoimmune hemolytic anemia. (يفتح نافذة جديدة)

Jordan SD, Alexander E.

Source‎: J Pharm Pract 2013;26(3):257-60.

مفهرسة‎: PubMed 22869910

DOI‎: 10.1177/0897190012451928

https://www.ncbi.nlm.nih.gov/pubmed/22869910 (يفتح نافذة جديدة)

The treatment of acute lymphoblastic leukemia in Jehovah's Witnesses and patients who cannot accept blood products. (يفتح نافذة جديدة)

Nguyen N, Madarang E, Alencar A, Watts J, Bradley T

Source‎: Leuk Res Rep. 2022 25;18:100355.

مفهرسة‎: PubMed 36338830

DOI‎: 10.1016/j.lrr.2022.100355

https://pubmed.ncbi.nlm.nih.gov/36338830/ (يفتح نافذة جديدة)

The use of recombinant factor VIIa in a Jehovah's Witness with auto-immune thrombocytopenia and post-splenectomy haemorrhage. (يفتح نافذة جديدة)

Waddington DP, McAuley FT, Hanley JP, Summerfield GP.

Source‎: Br J Haematol 2002;119(1):286-8.

مفهرسة‎: PubMed 12358947

https://www.ncbi.nlm.nih.gov/pubmed/12358947 (يفتح نافذة جديدة)

Thrombotic thrombocytopenic purpura treated with vincristine in a Jehovah's Witness. (يفتح نافذة جديدة)

Walia SS, Walia MS, Walia HS.

Source‎: Asian J Transfus Sci 2011;5(2):180-1.

مفهرسة‎: PubMed 21897605

DOI‎: 10.4103/0973-6247.83255

https://www.ncbi.nlm.nih.gov/pubmed/21897605 (يفتح نافذة جديدة)